文献速递小儿神经外科与脑积水

使用新型改良系留液态全氟化碳脑室导管减少实验性脑积水中的细胞表面附着

Reduction of cell surface attachment in experimental hydrocephalus using a novel ventricular catheter with modified tethered liquid perfluorocarbon.
PubMed 文献 · J Neurosurg · 2023-08-04

该研究在非脑积水大鼠中评估了改良系留液态全氟化碳(TLP)脑室导管的生物相容性,随后在30日龄幼猪脑积水模型中比较了TLP导管与临床对照导管的性能。结果显示TLP导管延长了动物生存时间、改善了临床评分并显著减少了导管上附着的细胞总数,但在脑室扩大、颅内压及局部组织反应方面与对照导管相似。作者认为TLP导管可能成为减少近端脑室导管梗阻的强候选方案。

要点

  • TLP脑室导管在非脑积水大鼠中植入30或60天后未引起脑炎症反应。
  • 在猪脑积水模型中,TLP导管较标准临床对照导管延长了生存时间并改善了临床评分。
  • TLP导管显著减少了导管上附着的细胞总数,但在脑室扩大和颅内压方面与对照相似。

核心结论

  • TLP脑室导管可能成为减少近端脑室导管梗阻并改善脑积水治疗的强候选方案。

研究设计与样本

  • 在大鼠中评估TLP脑室导管的生物相容性,确认安全后在30日龄幼猪中通过枕大池注射高岭土诱导脑积水并植入脑室腹腔分流管(临床对照或TLP)。
  • 手术植入于诱导后10-14天进行,维持至治疗后30天,并在治疗前及治疗后10天和30天进行MRI测量脑室体积。
  • 动物安乐死时进行脑组织和取出导管的组织学与免疫组化分析、颅内压测量及临床评分。

主要发现

  • TLP脑室导管与对照导管具有相似的手术手感、抗扭结性和硬度。
  • 在大鼠生物相容性评估中,TLP导管植入30或60天后未显示脑炎症反应。
  • 在猪中,TLP导管较标准临床对照导管增加了生存时间、改善了临床结局评分并显著减少了导管上附着的细胞总数。
  • TLP导管在脑室扩大、颅内压及猪皮层分流道周围局部组织反应方面与对照导管结果相似但未更差。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Ventriculoperitoneal shunting, the most common treatment for the neurological disorder hydrocephalus, has a failure rate of up to 98% within 10 years of placement, mainly because of proximal obstruction of the ventricular catheter (VC). The authors developed a new VC design modified with tethered liquid perfluorocarbon (TLP) and tested it in a porcine model of hydrocephalus. In this study, they aimed to determine if their TLP VC design reduced cell surface attachment and consequent shunt obstruction in the pig model. METHODS: TLP VCs were designed to reduce drainage hole obstruction using modified TLP and slightly enlarged draining holes, but their number and placement remained very similar to standard VCs. First, the authors tested the device in nonhydrocephalic rats to assess biocompatibility. After confirming safety, they implanted the VCs in hydrocephalic pigs. Hydrocephalus was induced by intracisternal kaolin injections in 30-day-old domestic juvenile pigs. Surgical implantation of the ventriculoperitoneal shunt (clinical control or TLP) was performed 10-14 days postinduction and maintained up to 30 days posttreatment. MRI was performed to measure ventricular volume before treatment and 10 and 30 days after treatment. Histological and immunohistochemical analyses of brain tissue and explanted VCs, intracranial pressure measurement, and clinical scoring were performed when the animals were euthanized. RESULTS: TLP VCs showed a similar surgical feel, kink resistance, and stiffness to control VCs. In rats (biocompatibility assessment), TLP VCs did not show brain inflammatory reactions after 30 or 60 days of implantation. In pigs, TLP VCs demonstrated increased survival time, improved clinical outcome scores, and significantly reduced total attached cells on the VCs compared with standard clinical control VCs. TLP VCs exhibited similar, but not worse, results related to ventriculomegaly, intracranial pressure, and the local tissue response around the cortical shunt track in pigs. CONCLUSIONS: TLP VCs may be a strong candidate to reduce proximal VC obstruction and improve hydrocephalus treatment.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Garcia-Bonilla M, Harris CA, Bandyopadhyay S, et al. Reduction of cell surface attachment in experimental hydrocephalus using a novel ventricular catheter with modified tethered liquid perfluorocarbon. J Neurosurg. 2023. PMID: 37542436. doi:10.3171/2023.5.JNS2355

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。